CoChat

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors

Wiedemeyer, Wolf Ruprecht · 2018 · Resistance to Targeted Anti-Cancer Therapeutics

Overview

Integrity signals

Registry

Crossref · 10.1007/978-3-319-67932-7_8

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 133 references

Cited by

See all 8

Metadata

Authors
Wiedemeyer, W. R.
Affiliations
Cedars-Sinai Medical Center (US)
Corresponding author
Wiedemeyer, Wolf Ruprecht
Venue
Resistance to Targeted Anti-Cancer Therapeutics
Published
2018
Pages
181-210
ISSN
  • 2196-5501 (ISSN-L)
  • 2196-551X
OpenAlex
W2795296107
Cited by
7
References
133
Citations by year
2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2
FWCI
4.12
Type
book chapter
Language
en
Open access
closed
Locations
Resistance to targeted anti-cancer therapeutics (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Advanced Breast Cancer Therapies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
cyclin-dependent kinase inhibitors, CDK4/6 inhibitors, acquired drug resistance, palbociclib, ribociclib, abemaciclib, dinaciclib, hormone receptor-positive breast cancer, estrogen receptor-positive breast cancer, MAPK signaling, PI3K signaling, RB1 mutation, cell cycle dysregulation, combination therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors. https://app.cochat.ai/papers/10.1007/978-3-319-67932-7_8
The paper
Wiedemeyer, W. R. (2018). Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors. Resistance to Targeted Anti-Cancer Therapeutics. https://doi.org/10.1007/978-3-319-67932-7_8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.